Gretchen Tamms

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · The Lancet Oncology · 2005 · 1.6K citations

Veterinary Medicine, Infectious Diseases, Oncology +17

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · British Journal of Cancer · 2006 · 808 citations · Full text

Medicine, Gynecology, Preventive Medicine +17

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

Luisa L. Villa, Kevin A. Ault, Anna R. Giuliano et al. · Vaccine · 2006 · 469 citations

Medicine, Immunology, Oncology +14

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

Sven‐Eric Olsson, Luisa L. Villa, Ronaldo Lúcio Rangel Costa et al. · Vaccine · 2007 · 456 citations

Life Sciences, Immunology, Infectious Diseases +16

Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine

Stan L. Block, Darron R. Brown, Archana Chatterjee et al. · The Pediatric Infectious Disease Journal · 2010 · 116 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17